kite pharma
EMA’s CHMP recommends conditional approval for Kite Pharma’s CAR T therapy for mantle cell lymphoma
October 20, 2020Manufacturing and Production, Sales and Marketing CAR T, CAR-T, CHMP, EMA, kite pharma, lymphoma
Kite Pharma’s anti-CD19 chimeric antigen receptor (CAR) T cell therapy known as KTE-X19 has received positive recommendation from the EMA’s …
Kite secures FDA approval for second CAR T therapy Tecartus in relapsed or refractory mantle cell lymphoma
July 27, 2020Sales and Marketing CAR T, CAR-T, FDA, Gilead, kite pharma
Kite Pharma has chalked up another regulatory success for its parent company Gilead with the news that the FDA has …
Gilead subsidiary Kite Pharma to open CAR-T manufacturing facility in Maryland
April 29, 2019Manufacturing and Production, Sales and Marketing CAR-T, Gilead, Manufacturing Facility, Maryland, kite pharma
Gilead Sciences subsidiary Kite Pharma has announced plans to open a new CAR-T manufacturing facility in Frederick County, Maryland (US). …
Gilead’s CAR-T therapy Yescarta rejected for NHS use in Scotland
February 12, 2019Manufacturing and Production, Sales and Marketing CAR-T, Cancer, Gilead, NHS, Scotland, Yescarta, kite pharma
It’s bad news for Scottish patients living with aggressive forms of non-Hodgkin lymphoma (NHL) as it emerges that the Scottish …
Gilead captures Kite in $11.9bn deal
August 29, 2017Manufacturing and Production, Sales and Marketing Gilead, biotech, drugs, kite pharma, pharma, pharmaceutical
Gilead had long been expected to make a serious acquisition to boost flagging growth and it finally made a move …
Kite Pharma climbs on strong data showing in lymphoma trial
March 1, 2017Research and Development kite pharma, non-Hodgkin lymphoma
Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …
Kite Pharma names new senior VP of Supply Chain
December 1, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, kite pharma
Santa-Monica-based clinical-stage biopharmaceutical firm Kite Pharma has appointed Dr Jian Irish as senior vice president of Supply Chain, who will …
Kite Pharma appoints Chris Nowers as Head of Europe
October 14, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Nowers, London, kite pharma
Kite Pharma announced on 13 October that it had appointed Chris Nowers as its Head of Europe. Nowers will be …
Kite Pharma flying high after promising Car-T trial
September 27, 2016Manufacturing and Production, Research and Development Cancer, Cart-T, kite pharma
Cart-T cell drugs are made by genetically altering patients’ T-cells to add a component of antibodies that make them better …
Kite Pharma names Paul Jenkinson CFO
May 23, 2016Research and Development, Sales and Marketing appointment, cfo, kite pharma
Kite Pharma (Nasdaq: KITE) has appointed Paul Jenkinson its chief financial officer. Jenkinson succeeds Cynthia Butitta, who will continue in her role as …
Kite Pharma, Roche to co-develop two new treatments for non-hodgkin lymphoma
March 18, 2016Medical Communications, Research and Development Gentech, Roche, kite pharma, non-Hodgkin lymphoma
Kite Pharma (Nasdaq: KITE) said it will collaborate with Swiss drug major Roche (SIX: ROG) to evaluate the safety and efficacy …
Kite Pharma says trial death was unrelated to KTE-C19
August 18, 2015Medical Communications, Research and Development CAR-T, cinical trials, kite pharma, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma
Kite has confirmed last week’s rumours that a patient had died during its Phase I/II trial for the KTE-C19 non-Hodgkin’s …
Amgen and Novartis start cancer immunotherapy push
January 7, 2015Research and Development, Sales and Marketing Amgen, Caribou Biosciences, Intellia Therapeutics, Novartis, kite pharma
Amgen and Novartis have launched new licensing agreements with biotech companies that they hope will lead to the development of …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
